Recursion Pharmaceuticals, Inc.RXRXNASDAQ
Loading
Net Income ContractionContracting
Percentile Rank0
Studio
Year-over-Year Change

Total earnings after all expenses, taxes, and interest

Latest
$-644.76M
↓ 124% vs avg
Percentile
P0
Near historical low
Streak
6 yr
Consecutive declineContracting
Average
$-287.42M
Historical baseline
PeriodValueYoY Change
TTM$-644.76M-39.1%
2024$-463.66M-41.3%
2023$-328.07M-37.0%
2022$-239.48M-28.4%
2021$-186.48M-114.3%
2020$-87.01M-39.2%
2019$-62.52M-